We are live on ! Find out more
ACM

Anfield Capital Management Portfolio holdings

AUM $363M
1-Year Est. Return 24.08%
This Fund
S&P 500
This Quarter Est. Return
-5.06%
1 Year Est. Return
+24.08%
3 Year Est. Return
+65.24%
5 Year Est. Return
+71.54%
10 Year Est. Return
AUM
$210M
AUM Growth
-$11.2M
Cap. Flow
+$714K
Cap. Flow %
0.34%
Top 10 Hldgs %
58.31%
Holding
94
New
2
Increased
41
Reduced
30
Closed
5
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HZNP
76
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$120K 0.06%
1,947
+60
+3% +$4.19K
CHE icon
77
Chemed
CHE
$7.22B
$71K 0.03%
163
+4
+3% +$1.92K
SDIV icon
78
Global X SuperDividend ETF
SDIV
$1.22B
$60K 0.03%
2,669
EXEL icon
79
Exelixis
EXEL
$13.4B
$55K 0.03%
3,531
+93
+3% +$1.8K
BKT icon
80
BlackRock Income Trust
BKT
$341M
$52K 0.02%
4,196
+292
+7% +$3.97K
CPRX
81
DELISTED
Catalyst Pharmaceutical
CPRX
$52K 0.02%
4,078
+95
+2% +$1.13K
HALO icon
82
Halozyme
HALO
$12.2B
$45K 0.02%
1,132
+39
+4% +$1.72K
CRSP icon
83
CRISPR Therapeutics
CRSP
$5.17B
$26K 0.01%
391
+18
+5% +$1.3K
IRWD icon
84
Ironwood Pharmaceuticals
IRWD
$714M
$19K 0.01%
1,799
+58
+3% +$658
AMPH icon
85
Amphastar Pharmaceuticals
AMPH
$916M
$17K 0.01%
614
+21
+4% +$686
INVA icon
86
Innoviva
INVA
$1.48B
$16K 0.01%
1,386
+36
+3% +$494
VIR icon
87
Vir Biotechnology
VIR
$1.49B
$15K 0.01%
790
+28
+4% +$712
QURE icon
88
uniQure
QURE
$3.22B
$14K 0.01%
751
+41
+6% +$862
EBS icon
89
Emergent Biosolutions
EBS
$248M
$11K 0.01%
508
+18
+4% +$501
PCN
90
PIMCO Corporate & Income Strategy Fund
PCN
$885M
-93,628
Closed -$1.18M
RAYC
91
DELISTED
Rayliant Quantamental China Equity ETF
RAYC
-9,487
Closed -$211K
RDVY icon
92
First Trust Rising Dividend Achievers ETF
RDVY
$25.6B
-5,000
Closed -$205K
XLF icon
93
State Street Financial Select Sector SPDR ETF
XLF
$58.8B
-1,273
Closed -$40K
XLY icon
94
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$23.8B
-480
Closed -$33K

Similar funds

Anfield Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Anfield Capital Management held 94 positions worth $210M, down 5.1% from $221M the previous quarter. Its ten largest holdings account for 58% of the portfolio.

Anfield Capital Management's Q3 2022 filing shows 2 new, 41 increased, 30 reduced and 5 closed positions. Its largest new stake was Blackstone Secured Lending: 14,135 shares worth $321K. The largest sale was PIMCO Corporate & Income Strategy Fund, an estimated $1.18M.

By sector, the portfolio is most concentrated in Real Estate at 1.8% of assets, down from 2% a quarter earlier, followed by Healthcare and Financials.

  • Anfield Capital Management's largest Q3 2022 buy was Blackstone Secured Lending: 14,135 shares worth $321K.
  • Anfield Capital Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2022, an estimated $677K increase.
  • Anfield Capital Management's biggest Q3 2022 reduction was Anfield Dynamic Fixed Income ETF, cutting an estimated $357K.
  • Anfield Capital Management fully exited PIMCO Corporate & Income Strategy Fund in Q3 2022, selling an estimated $1.18M.
  • Anfield Capital Management's ten largest holdings make up 58% of its $210M portfolio in Q3 2022.
  • Anfield Capital Management opened 2 new positions and closed 5 in Q3 2022.
  • Anfield Capital Management's portfolio value fell 5.1% quarter-over-quarter to $210M.

Based on Anfield Capital Management's 13F filing for Q3 2022, filed 9 Nov 2022.